Category Archives: UN General Assembly HLM

Open Letter to Ambassadors (in India) of RCEP negotiating countries by Delhi Network of Positive People

Open Letter to Ambassadors of RCEP negotiating countries  Member countries Must Consider the Impact of RCEP on Access to Medicines in Developing Countries  Don’t trade our lives away! We are writing to you on behalf of the Delhi Network of … Continue reading

Posted in Data Exclusivity, FTA, Investor state dispute, IPR Enforcement, LDC transition period, Regional Comprehensive Economic Partnership, TRIPS plus, UN General Assembly HLM | Leave a comment

UN High-Level Panel On Access To Medicines Issues “Landmark” Report

 BY Catherine Saez, Intellectual Property Watch| Sept 14, 2016 The long-awaited report by the United Nations High Level Panel on Access to Medicines was released today, making many recommendations. The panel calls for countries to embrace the policy space available … Continue reading

Posted in R&D, UN General Assembly HLM, Uncategorized | Leave a comment

UN panel blames capitalism, property rights for lack of access to medicines in poor nations

By Tom Giovanetti, Fox News | Sept 14, 2016 On Wednesday morning, a special United Nations High Level Panel on Access to Medicines released its findings—findings that have been long-awaited by the non-governmental organizations (NGOs) that drove its formation, and long-dreaded … Continue reading

Posted in UN General Assembly HLM, Uncategorized | Leave a comment

Report of the UN Secretary-General’s High-Level Panel on human rights and medicines: Oxfam’s response

Source: Oxfam In December 2015, the UN Secretary-General set up a High-Level Panel on Access to Medicines to ‘recommend solutions for remedying the policy incoherence between the justifiable rights of inventors, international human rights law, trade rules and public health … Continue reading

Posted in UN General Assembly HLM, Uncategorized | Leave a comment

UN REPORT STRENGTHENS CASE FOR PATENT LAW REFORM IN SA AND OTHER DEVELOPING COUNTRIES

Source: Treatment Action Campaign JOHANNESBURG, 14th SEPTEMBER 2016: The Treatment Action Campaign (TAC) and SECTION27 welcome the release of the United Nation Secretary General’s High-Level Panel Report on Access to Medicines. This UN report makes a number of important recommendations … Continue reading

Posted in UN General Assembly HLM, Uncategorized | Leave a comment

PhRMA Response to Colombia’s Decision to Enforce a Declaration of Public Interest

Source: PhRMa WASHINGTON (September 14, 2016) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President, International, Brian Toohey, issued the following statement on Colombia’s enforcement of a Declaration of Public Interest: “We are very disappointed that Colombia has … Continue reading

Posted in UN General Assembly HLM, Uncategorized | Leave a comment

HEALTH GAP STATEMENT ON THE FINAL REPORT OF THE UN SECRETARY-GENERAL’S HIGH LEVEL PANEL ON ACCESS TO MEDICINES

Source: Health Gap| Global Access Project (Sept. 14, 2016) The High Level Panel’s (HLP) Final Report correctly identifies a high degree of policy incoherence between the interests of inventors – protected by national and international intellectual property law and trade … Continue reading

Posted in UN General Assembly HLM, Uncategorized | Leave a comment